6月27日,北京首钢朗泽科技股份有限公司通过港交所主板上市聆讯,国泰君安国际为独家保荐人。该公司深耕碳捕集、利用与封存(CCUS)领域,是行业内首家实现合成生物技术商业化生产低碳产品的企业。招股书显示,2022年至2024年,公司收入分别为3.9亿元、5.93亿元、5.64亿元,但同期亏损扩大,毛利率由正转负。首钢集团为控股股东,持股约26.54%,其他主要股东包括NZ Tang Ming、曹妃甸...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.